← FDA Drug Approvals (Drugs@FDA)

CARBAGLU

NDA · New Drug Application · Sponsor: RECORDATI RARE · Approved 2010-03-18

Drug application

FDA Application #

NDA022562

Application type

New Drug Application

Brand name

CARBAGLU

Generic name

CARGLUMIC ACID

Active ingredients

CARGLUMIC ACID

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

RECORDATI RARE

Manufacturer

Recordati Rare Diseases

First approval

2010-03-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown